Trial Profile
A retrospective study evaluating impact of adherence to pomalidomide on medication adherence in pre-existing chronic conditions in patients with multiple myeloma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jun 2018
Price :
$35
*
At a glance
- Drugs Pomalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 28 Jun 2018 New trial record
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology